The FinancialContent Network     SocialPicks Community   |   MarketMinute Monitor   |   MarketMinute Market Updates   |   MarketMinute Stock News
SocialPicks
   Sign Up   |   Log In   |   What is SocialPicks?     

 Barr Pharmaceuticals Inc.  (BRL) Trade Now »     Rate BRL  -  Discuss BRL  -  Add to Watch List         Graphic_subscribe

       Sector: Healthcare  >  Industry: Biotechnology & Drugs
SocialPicks Sentiment:

** v.s. other stocks 		This Quarter's Sentiment:
All:
64.0%
Top:
100.0%
Rate BRL:


Home
Analysis & Videos
Quotes
Bull or Bear
Discuss
        

BRL: Bull or Bear? From:    SocialPicks  |  Blogsphere  |  All

From the Blogosphere

Roche Offers To Buy Genentech…
Logo1
38%
<>

Well the rest of the 44% stake that it already does not own. Roche, which happens to be Switzerland’s largest drugmaker, is offering $43.7 billion for that 44% stake, to gain complete access to Genentech’s (DNA) cancer drugs. The $43.7 billion dollars, translates into $89 per share for each Genentech share, an 8.8% premium to the Friday 07/18/08 closing price of $81.82.

Genentech (DNA) has already proven to be a worthwhile investment for Roche, as the drug maker has provided Roche with its best-selling cancer drugs Avastin, Herceptin and Rituxan. 

<>Drug related sto...
By  StraightStocks   (-6.13%  risk: moderate)  07/21/08 Comment


Analyst upgrades: TEVA, WFMI, CTAS, BCSI and AIG

Filed under: Analyst upgrades and downgrades, Cintas Corp (CTAS), Whole Foods Market (WFMI), Amer Intl Group (AIG), Teva Pharm Indus ADR (TEVA)

MOST NOTEWORTHY: Teva Pharmaceutical, Blue Coat Systems and American International Group were today's noteworthy upgrades:
<>
  • Deutsche Bank upgraded shares of Teva Pharmaceutical (NASDAQ: TEVA) to Buy from Hold to reflect the company's greater growth prospects following the acquisition of Barr (NYSE: BRL). The firm raised the target to $56 from $47.
    • <>ThinkPanmure upgraded Blue Coat Systems (NASDAQ: BCSI) to Buy from Source of Funds based on the c...
    By  Eric Buscemi   (+0.00%)  07/21/08 Comment


    Analyst downgrades: SWK, Generic drug sector, FISV and FIS

    Filed under: Analyst upgrades and downgrades, Teva Pharm Indus ADR (TEVA)

    MOST NOTEWORTHY: Stanley Works, the Generic Drug sector, Fiserv and Fidelity National were today's noteworthy downgrades:
    <>
  • Deutsche Bank downgraded shares of Stanley Works (NYSE: SWK) to Hold from Buy as they see risk to Q2 and FY08 earnings due to a slowdown in the European industrial and consumer categories. The firm lowered their target to $52 from $62.
    • <>Wachovia cut the Generic Drug sector to Market Weight from Overweight Wachovia sees near-term challenges for Teva Pharmaceutical (NASDAQ: TEVA), Mylan (NYSE: ...
    By  Eric Buscemi   (+0.00%)  07/21/08 Comment


    Generic Drug Industry Consolidation Is Underway
    Logo1
    38%
    The long overdue consolidation in the generic drug industry appears to be in full swing based on about $15 billion in deals announced recently. Teva Pharma (TEVA) is the largest public company in the generic drug industry with a $34.8 billion market cap, which just got even bigger with a $7.5 billion buyout of Barr Pharma (BRL) that follows a smaller $350 million deal announced earlier for Bentley Pharma (BNT). Other recent deals in the generic industry include a $2.7 billion offer for Czech-based Zentiva (which the company has officially rejected as of today) and a $4.6 billion buyout of I...
    By  StraightStocks   (-6.13%  risk: moderate)  07/18/08 Comment


    Generic Drug Industry Consolidation Is Underway
    Logo1
    38%
    The long overdue consolidation in the generic drug industry appears to be in full swing based on about $15 billion in deals announced recently. Teva Pharma (TEVA) is the largest public company in the generic drug industry with a $34.8 billion market cap, which just got even bigger with a $7.5 billion buyout of Barr Pharma (BRL) that follows a smaller $350 million deal announced earlier for Bentley Pharma (BNT). Other recent deals in the generic industry include a $2.7 billion offer for Czech-based Zentiva (which the company has officially rejected as of today) and a $4.6 billion buyout of I...
    By  StraightStocks   (-6.13%  risk: moderate)  07/18/08 Comment



    ROCK-STAR INVESTORS
    Rank Name Sharpe Ratio Avg Return Followers
    1 noshoes 21.10 +34.44% 381
    2 Gerald Greene 18.14 +71.24% 211
    3 stockmarketfunding.com 17.66 +25.60% 55
    4 akiralegrand 13.47 +14.32% 62
    5 anup2104 12.13 +74.22% 40


    POPULAR STOCKS
    Symbol Company Name Sentiment
    MSFT Microsoft Corp
    MCD McDonald's Corp.
    DELL Dell Inc
    CSCO Cisco Systems Inc
    DRYS DryShips Inc.
    WMT WalMart Stores Inc

    TODAY'S HEADLINES

    TODAY'S TOP PICKS

    		 

    StreetInsider.com on BRL

    Visit streetinsider.com


    Discussion Wall + Add  

    Be the first to start a discussion and earn 2 points.



    More Resources

    Graphic_arrow1 About Barr Pharmaceuticals Inc. - Answers.com

    Graphic_arrow1 Historical Prices - Yahoo

    Graphic_arrow1 Message Boards - BoardCentral.com

    Graphic_arrow1 More Info:     Yahoo   |   Google   |   Reuters




    		IN THE PRESS
    Press_forbes Press_washingtonpost Press_wsj Press_npr Press_techcrunch